82 related articles for article (PubMed ID: 2092725)
1. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
[TBL] [Abstract][Full Text] [Related]
2. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
3. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
Br J Cancer; 1990 Dec; 62(6):1047-51. PubMed ID: 2257212
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
6. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
García-Plata D; Mozos E; Carrasco L; Solana R
Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
[TBL] [Abstract][Full Text] [Related]
7. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
8. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
9. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
10. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
Niu C; Liu X; Zhou W; Jing L; Du B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
[TBL] [Abstract][Full Text] [Related]
11. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of HLA DR expression and lymphocytic infiltrate in laryngeal cancer including clinical and morphological correlations.
Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
Gen Diagn Pathol; 1998 Apr; 143(5-6):297-303. PubMed ID: 9653911
[TBL] [Abstract][Full Text] [Related]
13. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological malignancy and prognosis of laryngeal cancer].
Solano J; Esteban F; Delgado M; González M; Zaragoza L
Acta Otorrinolaringol Esp; 1997; 48(5):375-82. PubMed ID: 9376158
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
[TBL] [Abstract][Full Text] [Related]
19. [Several blood group antigens expressions in laryngeal cancer tissue and their clinical significance].
Ji W; Fei S; Pan Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):330-2. PubMed ID: 7742021
[TBL] [Abstract][Full Text] [Related]
20. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
Zhang C; Tian Z; Hou G
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
